VIJAYA — Vijaya Diagnostic Centre Balance Sheet
0.000.00%
- IN₹136.77bn
- IN₹138.10bn
- IN₹8.14bn
Annual balance sheet for Vijaya Diagnostic Centre, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,466 | 2,554 | 1,834 | 2,810 | 2,891 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 148 | 132 | 176 | 150 | 209 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,699 | 2,757 | 2,113 | 3,072 | 3,219 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,979 | 5,435 | 6,104 | 7,940 | 9,639 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,135 | 8,534 | 9,828 | 12,736 | 15,070 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 661 | 662 | 729 | 1,626 | 1,239 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,452 | 3,087 | 3,256 | 4,779 | 5,499 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4,682 | 5,447 | 6,572 | 7,957 | 9,572 |
| Total Liabilities & Shareholders' Equity | 7,135 | 8,534 | 9,828 | 12,736 | 15,070 |
| Total Common Shares Outstanding |